FAQs

  • An early health technology assessment (eHTA) supports the understanding of the commercial potential of technology, and the evidence requirements and the decision needs of payers to purchase the technology.

  • eHTA provides valuable insight for technology transfer professionals and companies that are developing a healthcare technology. eHTA is also very useful for organizations that have a number of options in terms of research projects or companies to select for support services, investment or grant funding. In this context, eHTA can support prioritization and selection decision-making through comparative candidate product analysis. eHTA provides the investment and granting community opportunity to more fully understand the commercial potential of technology in development, and the time and cost required to reach the market, in order to support vetting and triaging of promising technologies for detailed due diligence

  • The work of the Assessor community on the ASSESS Platform primarily considers the U.S., Canadian, Western European, Australian, and New Zealand markets in their analysis. Currently, Assessors on the platform have the ability to assess technologies from the perspective of 42 different markets.

  • The ASSESS Project facilitates access to global experts in health technology assessment and health economic modelling, to assess the investment, trial and adoption cases for life sciences technology development and commercialization. The project has a specific focus on the evidence requirements and decision criteria of health care payers.   The project does not use a typical consulting agency model with generally fixed internal staff resources.  Rather, it uses a secure web platform, The ASSESS Platform, to source Assessors and modellers from a global community, to match project requirements to the specific skill set, expertise, experience, and market-specific knowledge related to a particular type of technology and therapeutic application.  

  • The ASSESS Project has a goal to substantially reduce time and cost for an eHTA and health economic modelling, and concurrently significantly improve accessibility, quality and utility. The intended outcomes are substantially more eHTAs and modelling exercises completed, better deployment of human and financial capital, greater health and economic outcomes achieved, and greater investment returns for start-ups, technology transfer offices, and the investment community.

  • A strong international team of Co-Creators and Advisors have come together to develop The ASSESS Project. The legal entities responsible for the project are Birota Economics Group Inc., and Birota Economics Group USA Inc.

  • Please visit https://assessplatform.com to request an assessment, or to join the Assessor community.

Join the Community.